stella
beta
Clinical Study of XPO1 Inhibitor Selinexor Combined With COPL in Newly Diagnosed Advanced NK/T-cell Lymphoma — Stella
Recruiting
Back to nk/T-cell Lymphoma trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
ChinaPLAGH, Beijing, Haidian
View full record on ClinicalTrials.gov